Intelligent Engagement in the LatAm Market: Q&A with Eduardo Alonso, Aktana Head of Customer Success
The Veeva Commercial Summit in Sao Paulo is right aroun […]
Novartis and Aktana at Veeva Summit: Building the AI-Driven Commercial Engagement Model
We returned as a platinum sponsor once again to the Vee […]
Three Principles of Agile HCP Engagement
The demand for AI-driven personalization and cohesive e […]
Industry Leaders Come Together to Discuss Intelligent Customer Engagement at the 2019 Aktana Innovators Forum
We recently hosted our annual Aktana Innovators Forum i […]
A view from Japan: Helping reps better understand customer needs
Meeting the expectations of healthcare providers (HCPs) […]
The Democratization of Machine Learning in Commercial Life Sciences
Machine learning is easily one of the most heavily disc […]
The Essential Role of In-House Analytics
Across industries, innovators are finding ways to use d […]
Novartis’s Intelligent “Personal Assistant” Facilitates More Meaningful HCP Interactions
Life sciences organizations are continuing to adopt dig […]
Four AI trends making commercial life sciences smarter in 2019
Artificial intelligence (AI) has already proved to be useful when it comes to life sciences R&D, starting to fruitfully aid in plumbing the vast depths of discovery, clinical, and real-world data. However, the benefits of AI are now making themselves known on the business side of the life sciences industry, enabling commercial teams to better understand and address the needs of the healthcare providers and patients they serve. In 2019, the following trends will help to define how AI can become better integrated into the commercial side of life sciences businesses.
From Manual to Automation: MSD Personalizes Individual HCP Interactions
It’s no secret that customer centricity and personaliza […]